Cargando…
Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B‐cell acute lymphoblastic leukemia
Patients with B‐lineage acute lymphoblastic leukemia treated with pegasparaginase‐containing regimens can develop hepatotoxicity related to it. The systemic hyperbilirubinemia due to hepatotoxicity can lead to the development of CSF xanthochromia.
Autores principales: | Moia, Riccardo, Greco, Mariangela, Boggione, Paola, Nicolosi, Maura, Bruna, Riccardo, Patriarca, Andrea, Gaidano, Gianluca, Lunghi, Monia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669392/ https://www.ncbi.nlm.nih.gov/pubmed/33235781 http://dx.doi.org/10.1002/ccr3.3114 |
Ejemplares similares
-
First-line treatment of acute lymphoblastic leukemia with pegasparaginase
por: Masetti, Riccardo, et al.
Publicado: (2009) -
Pseudo-Froin's syndrome, xanthochromia with high protein level of cerebrospinal fluid
por: Kwon, Soon-Kul, et al.
Publicado: (2014) -
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
por: Moia, Riccardo, et al.
Publicado: (2021) -
An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient
por: Bruna, Riccardo, et al.
Publicado: (2020) -
Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
por: Crisà, Elena, et al.
Publicado: (2021)